Clearstead Trust’s NeoGenomics NEO Stock Holding History

Clearstead Trust’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23	Closed	-$178	–	1347
2025 Q3	$178	Hold	23	–	–	﹤0.01%	1504
2025 Q2	$169	Buy	+23	New	+$186	﹤0.01%	1482

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Clearstead Trust's NEO Position: Q4 2025 in Review

Clearstead Trust sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 23 shares — an estimated $178 sold.

Clearstead Trust first reported a position in NEO in Q2 2025 and held it in 2 quarters. The position peaked at $178 in Q3 2025. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.

Clearstead Trust reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 23 NeoGenomics shares in Q4 2025, an estimated $178.
Clearstead Trust first reported a position in NeoGenomics in Q2 2025 and held it in 2 quarters.
Clearstead Trust's NeoGenomics position peaked at $178 in Q3 2025.
256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.